Cargando…
Inhibition of P2X7 Purinergic Receptor Ameliorates Cardiac Fibrosis by Suppressing NLRP3/IL-1β Pathway
P2X7 purinergic receptor (P2X7R) has been implicated in several cardiovascular diseases. However, whether it regulates cardiac fibrosis remains elusive. Herein, its involvement in the development of cardiac fibrosis was examined using a transverse aortic constriction (TAC) mice model and cardiac fib...
Autores principales: | Zhou, Junteng, Tian, Geer, Quan, Yue, Li, Junli, Wang, Xiaojiao, Wu, Wenchao, Li, Miaoling, Liu, Xiaojing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261319/ https://www.ncbi.nlm.nih.gov/pubmed/32566102 http://dx.doi.org/10.1155/2020/7956274 |
Ejemplares similares
-
Purinergic P2 Receptors: Novel Mediators of Mechanotransduction
por: Kong, Qihang, et al.
Publicado: (2021) -
Inhibition of P2X7 Purinergic Receptor Ameliorates Fibromyalgia Syndrome by Suppressing NLRP3 Pathway
por: D’Amico, Ramona, et al.
Publicado: (2021) -
Voltage-dependent anion channel 1 (VDAC1) overexpression alleviates cardiac fibroblast activation in cardiac fibrosis via regulating fatty acid metabolism
por: Tian, Geer, et al.
Publicado: (2023) -
The long noncoding RNA THBS1-AS1 promotes cardiac fibroblast activation in cardiac fibrosis by regulating TGFBR1
por: Zhou, Junteng, et al.
Publicado: (2023) -
Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis
por: Chen, Yan, et al.
Publicado: (2022)